Italo Biaggioni1. 1. Department of Medicine and Pharmacology, Division of Clinical Pharmacology, Vanderbilt University, Nashville, Tennessee 37212, USA. Italo.biaggioni@vanderbilt.edu
Abstract
PURPOSE OF THE REVIEW: Inappropriate sympathetic overactivity is consistently observed in patients with essential hypertension. The present review summarizes the recent advances that have been made in our understanding of the role of the sympathetic nervous system in hypertension. RECENT FINDINGS: Studies in patients with autonomic disorders underscore the role of the sympathetic nervous system in the long-term maintenance of hypertension. Abnormalities in the afferent limb of the sympathetic nervous system, in the regulation of central neurons where sympathetic outflow originates, and in the modulation of efferent sympathetic function, can all produce autonomic disorders that are associated with hypertension. More subtle dysfunctions in any of these components have been described in essential hypertension and can contribute to its pathogenesis. These include impaired buffering capacity of arterial baroreflexes, increased central sympathetic outflow, and enhanced norepinephrine release (or decrease reuptake) from sympathetic nerve terminals. Whether genetic polymorphisms of adrenoreceptors are associated with essential hypertension is an area of active research. SUMMARY: Increased sympathetic activity can contribute to sustained hypertension not only because of its hemodynamic effects (increased cardiac output and vascular resistance), but also by altering renal and water handling by the kidney, and by inducing cardiac and vascular remodeling. Antihypertensive agents that directly or indirectly target this sympathetic overactivity may be particularly useful in long-term treatment of essential hypertension.
PURPOSE OF THE REVIEW: Inappropriate sympathetic overactivity is consistently observed in patients with essential hypertension. The present review summarizes the recent advances that have been made in our understanding of the role of the sympathetic nervous system in hypertension. RECENT FINDINGS: Studies in patients with autonomic disorders underscore the role of the sympathetic nervous system in the long-term maintenance of hypertension. Abnormalities in the afferent limb of the sympathetic nervous system, in the regulation of central neurons where sympathetic outflow originates, and in the modulation of efferent sympathetic function, can all produce autonomic disorders that are associated with hypertension. More subtle dysfunctions in any of these components have been described in essential hypertension and can contribute to its pathogenesis. These include impaired buffering capacity of arterial baroreflexes, increased central sympathetic outflow, and enhanced norepinephrine release (or decrease reuptake) from sympathetic nerve terminals. Whether genetic polymorphisms of adrenoreceptors are associated with essential hypertension is an area of active research. SUMMARY: Increased sympathetic activity can contribute to sustained hypertension not only because of its hemodynamic effects (increased cardiac output and vascular resistance), but also by altering renal and water handling by the kidney, and by inducing cardiac and vascular remodeling. Antihypertensive agents that directly or indirectly target this sympathetic overactivity may be particularly useful in long-term treatment of essential hypertension.
Authors: Yoskaly Lazo-Fernandez; Greti Aguilera; Truyen D Pham; Annie Y Park; William H Beierwaltes; Roy L Sutliff; Jill W Verlander; Karel Pacak; Adeboye O Osunkoya; Carla L Ellis; Young Hee Kim; Gregory L Shipley; Brandi M Wynne; Robert S Hoover; Shurjo K Sen; Paul M Plotsky; Susan M Wall Journal: Am J Physiol Endocrinol Metab Date: 2015-07-14 Impact factor: 4.310
Authors: Cheri L McGowan; David N Proctor; Ian Swaine; Robert D Brook; Elizabeth A Jackson; Phillip D Levy Journal: Curr Hypertens Rep Date: 2017-06 Impact factor: 5.369
Authors: Larisa A Fedoseeva; Leonid O Klimov; Nikita I Ershov; Vadim M Efimov; Arcady L Markel; Yuriy L Orlov; Olga E Redina Journal: BMC Genomics Date: 2019-05-08 Impact factor: 3.969
Authors: Dinesh A Barawkar; Ashwin Meru; Anish Bandyopadhyay; Abir Banerjee; Anil M Deshpande; Chandrashekhar Athare; Chandrasekhar Koduru; Goraksha Khose; Jayasagar Gundu; Koshu Mahajan; Pradeep Patil; Sachin R Kandalkar; Sanjay Niranjan; Shubhangi Bhosale; Siddhartha De; Sudit Mukhopadhyay; Sumit Chaudhary; Summon Koul; Umesh Singh; Anita Chugh; Venkata P Palle; Kasim A Mookhtiar; Joseph Vacca; Prasun K Chakravarty; Ravi P Nargund; Samuel D Wright; Sophie Roy; Michael P Graziano; Sheo B Singh; Doris Cully; Tian-Quan Cai Journal: ACS Med Chem Lett Date: 2011-10-07 Impact factor: 4.345
Authors: Christoph Schroeder; Karsten Heusser; Jens Tank; André Diedrich; Friedrich C Luft; Jens Jordan Journal: Clin Auton Res Date: 2008-11-15 Impact factor: 4.435